159
Views
21
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis, spectroscopic, and biological studies on copper(II) complexes containing equatorial–apical chloride bridges: crystal structure of [Cu2(μ-Cl)2(O-2-butoxyethylpyridine-2-carboximidate)2Cl2]

, , , , , & show all
Pages 891-909 | Received 11 Sep 2013, Accepted 09 Jan 2014, Published online: 07 Apr 2014
 

Abstract

Three new [Cu2(μ-Cl)2(O-2-alkoxyethylpyridine-2-carboximidate)2Cl2] complexes, where alkoxy = methoxy, ethoxy, and butoxy, were synthesized and characterized by elemental analyses, FTIR spectra, electronic spectra, EPR, conductance, magnetic moment, powdered X-ray powder diffraction, and X-ray single-crystal diffraction. The three complexes contain chloride as a bridging ligand and in each complex the planar bidentate ligand binds the metal ion via the pyridine-N and the NH of the imino ether group. The X-ray crystal structure of [Cu2(μ-Cl)2(O-2-butoxyethylpyridine-2-carboximidate)2Cl2] shows that it crystallizes as a centrosymmetric dinuclear species in which each copper(II) is in a distorted square pyramid. Magnetic field-induced partial molecular alignment has been observed in polycrystalline samples of 2 and 3 when cooled in a magnetic field of 1 T at 77 K. The interaction of these complexes with Calf thymus DNA has been explored and the values of binding constant, Kb for 1, 2, and 3 are 1.524 × 103, 5.587 × 103, and 6.362 × 103 (ML−1)−1, respectively. Complexes were screened for antimicrobial activities by the agar well diffusion technique.

Graphical Abstract

Acknowledgement

One of the authors (R.K. Bindiya Devi) gratefully acknowledges the financial support from the UGC-BSR fellowship.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.